LifeStance Reports Fourth Quarter and Full Year 2025 Results

Financial Performance - LifeStance Health Group reported fourth quarter revenue of $382.2 million, a 17% increase year-over-year, and full year revenue of $1,424.3 million, up 14% from the previous year [3][4] - The company achieved a net income of $11.7 million in Q4 and $9.7 million for the full year, compared to a net loss of $7.1 million and $57.4 million in the prior year respectively [3][4] - Adjusted EBITDA for Q4 was $48.8 million, reflecting a 49% increase, and for the full year, it grew 32% to $157.7 million [5][23] Operational Highlights - The clinician base increased by 9% to 8,040, with a net increase of 44 clinicians in Q4 and 657 for the full year [3][4] - Visit volumes rose 18% in Q4 to 2.4 million and increased 14% for the full year to 9.0 million [3][4] Cash Flow and Capital Allocation - LifeStance generated $146.2 million in cash flow from operations for the year, including $57.6 million in Q4 [6][19] - The company announced a $100 million share repurchase program, indicating strong cash generation and a healthy balance sheet [7][12] 2026 Guidance - For the full year 2026, LifeStance expects revenue between $1.615 billion and $1.655 billion, with a Center Margin of $526 million to $550 million, and Adjusted EBITDA of $185 million to $205 million [12][7]